Orygen
Clinical trials sponsored by Orygen, explained in plain language.
-
New staged treatment shows promise for preventing psychosis in At-Risk youth
Disease control CompletedThis study tested a step-by-step treatment approach for 342 young people aged 12-25 who are at ultra high risk of developing psychosis. The goal was to see if a sequence of therapies and medications could improve daily functioning and reduce the chance of psychosis. The approach …
Phase: PHASE3 • Sponsor: Orygen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Talking therapy tested for picky eating disorder in teens and young adults
Symptom relief CompletedThis trial tests whether a type of talking therapy called CBT-AR can help young people aged 12 to 25 with avoidant/restrictive food intake disorder (ARFID). ARFID is an eating disorder where people avoid certain foods or eat very little, not because of body image concerns but due…
Phase: NA • Sponsor: Orygen • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC